Novo Nordisk A/S ADR buy BTIG Research
Start price
29.03.23
/
50%
€144.50
Target price
29.03.24
€28.58
Performance (%)
-16.96%
End price
30.03.24
€120.00
Summary
This prediction ended on 30.03.24 with a price of €120.00. The price of Novo Nordisk A/S ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.96%. Dividends of €1.43 are taken into consideration when calculating the performance. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Novo Nordisk A/S ADR | -3.226% | -3.226% | 23.821% |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by BTIG_Research for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at BTIG Research from $20.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten